Scarica l'app Stockscreener
14.80
2.97%
-0.4412
Precedente Chiudi:
$15.24
Aprire:
$15.13
Volume 24 ore:
33,821
Relative Volume:
0.22
Capitalizzazione di mercato:
$129.13M
Reddito:
$123.24M
Utile/perdita netta:
$136.00K
Rapporto P/E:
-739.94
EPS:
-0.02
Flusso di cassa netto:
$-148.99M
1 W Prestazione:
-13.83%
1M Prestazione:
-28.18%
6M Prestazione:
+53.56%
1 anno Prestazione:
-8.43%
Intervallo 1D:
$14.37
$15.34
Intervallo di 1 settimana:
$14.37
$17.37
Portata 52W:
$6.53
$24.67
Seres Therapeutics Inc Stock (MCRB) Company Profile
Nome
Seres Therapeutics Inc
Settore
Industria
Telefono
617 945 9626
Indirizzo
200 SIDNEY STREET, CAMBRIDGE, MA
Confronta MCRB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MCRB
Seres Therapeutics Inc
|
14.75 | 133.42M | 123.24M | 136.00K | -148.99M | -0.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.82 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.01 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.17 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
841.94 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.52 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Seres Therapeutics Inc Stock (MCRB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-08 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2024-10-24 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-04-21 | Iniziato | JP Morgan | Neutral |
| 2021-07-23 | Downgrade | Goldman | Neutral → Sell |
| 2021-05-18 | Ripresa | Goldman | Neutral |
| 2021-03-05 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-09-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2020-08-18 | Iniziato | Piper Sandler | Overweight |
| 2020-08-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-04-30 | Iniziato | Jefferies | Hold |
| 2018-10-22 | Iniziato | Chardan Capital Markets | Buy |
| 2017-10-13 | Iniziato | Oppenheimer | Outperform |
| 2017-08-04 | Reiterato | H.C. Wainwright | Buy |
| 2017-02-01 | Reiterato | FBR & Co. | Outperform |
| 2016-08-12 | Reiterato | FBR Capital | Outperform |
| 2016-08-01 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2016-08-01 | Reiterato | H.C. Wainwright | Buy |
| 2016-07-29 | Ripresa | H.C. Wainwright | Buy |
| 2016-03-30 | Iniziato | FBR Capital | Outperform |
| 2016-03-03 | Iniziato | Guggenheim | Buy |
| 2016-01-25 | Iniziato | H.C. Wainwright | Buy |
| 2015-10-22 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2015-07-22 | Iniziato | Canaccord Genuity | Buy |
| 2015-07-21 | Iniziato | Goldman | Neutral |
| 2015-07-21 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Seres Therapeutics Inc Borsa (MCRB) Ultime notizie
Signal strength of Seres Therapeutics Inc. stock in tech scannersPortfolio Value Summary & AI Based Buy/Sell Signal Reports - newser.com
Is Seres Therapeutics Inc. stock a buy on dipsTrade Volume Summary & Weekly High Momentum Picks - newser.com
Analyzing Seres Therapeutics Inc. with risk reward ratio chartsJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - newser.com
Will Seres Therapeutics Inc. (1S90) stock extend growth storyTrade Ideas & Daily Stock Trend Reports - newser.com
Is Seres Therapeutics Inc. stock supported by innovation pipeline2025 Volatility Report & Daily Growth Stock Investment Tips - newser.com
How interest rate cuts could boost Seres Therapeutics Inc. stockJuly 2025 Patterns & AI Forecast Swing Trade Picks - newser.com
What market sentiment indicators show for Seres Therapeutics Inc. (1S90) stock2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com
Can volume confirm reversal in Seres Therapeutics Inc.2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
Will Seres Therapeutics Inc. stock split attract more investorsJuly 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com
Is Seres Therapeutics Inc. stock a contrarian buy2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com
Key metrics from Seres Therapeutics Inc.’s quarterly data2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
Published on: 2025-11-03 00:21:05 - newser.com
Published on: 2025-11-02 23:51:16 - newser.com
Is Seres Therapeutics Inc. stock recession proof2025 Year in Review & Daily Stock Trend Reports - newser.com
Analyzing Seres Therapeutics Inc. with multi timeframe chartsDollar Strength & Risk Managed Investment Strategies - newser.com
Institutional scanner results for Seres Therapeutics Inc.July 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving AverageTime to Sell? - MarketBeat
Is Seres Therapeutics Inc. stock attractive for hedge fundsEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Backtesting results for Seres Therapeutics Inc. trading strategiesWeekly Profit Report & Safe Capital Growth Stock Tips - newser.com
Seres Therapeutics (MCRB) to Release Earnings on Wednesday - MarketBeat
Published on: 2025-11-01 01:46:58 - newser.com
How Seres Therapeutics Inc. (1S90) stock moves on employment dataExit Point & Daily Stock Trend Reports - newser.com
Operating cash flow per share of Seres Therapeutics Inc – BX:MCRB - TradingView
Is Seres Therapeutics Inc. (1S90) stock a buy before earnings resultsWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com
Published on: 2025-10-31 04:08:39 - newser.com
News impact scoring models applied to Seres Therapeutics Inc.Quarterly Portfolio Summary & Long-Term Safe Investment Plans - newser.com
Seres Therapeutics, Inc. (MCRB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Seres Therapeutics (MCRB) Price Target Decreased by 62.44% to 16.32 - MSN
Leading vs lagging indicators on Seres Therapeutics Inc. performanceEarnings Overview Summary & Low Volatility Stock Suggestions - newser.com
Published on: 2025-10-30 06:05:42 - newser.com
Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025 - MarketScreener
Nov. 5 at 8:30 a.m. ET: Seres Therapeutics (NASDAQ: MCRB) hosts third-quarter results call - Stock Titan
Published on: 2025-10-30 04:27:10 - newser.com
Seres Therapeutics Inc Azioni (MCRB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.52%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):